Literature DB >> 25047368

Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?

Tobias Maurer1, Ambros J Beer, Hans-Jürgen Wester, Hubert Kübler, Markus Schwaiger, Matthias Eiber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25047368     DOI： 10.1111/iju.12577

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  8 in total

1.  Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.

Authors:  Christoph Rischpler; Tobias Maurer; Markus Schwaiger; Matthias Eiber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-27       Impact factor: 9.236

Review 2.  Anatomic and Molecular Imaging in Prostate Cancer.

Authors:  Eric T Miller; Amirali Salmasi; Robert E Reiter
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 3.  Current use of PSMA-PET in prostate cancer management.

Authors:  Tobias Maurer; Matthias Eiber; Markus Schwaiger; Jürgen E Gschwend
Journal:  Nat Rev Urol       Date:  2016-02-23       Impact factor: 14.432

4.  [Positron-emission tomography in urooncology].

Authors:  T Maurer; H Kübler; J E Gschwend; M Eiber
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

5.  68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost.

Authors:  Lena Thomas; Steffi Kantz; Arthur Hung; Debra Monaco; Florian C Gaertner; Markus Essler; Holger Strunk; Wolfram Laub; Ralph A Bundschuh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-21       Impact factor: 9.236

6.  Multimodal image-guided prostate fusion biopsy based on automatic deformable registration.

Authors:  Oliver Zettinig; Amit Shah; Christoph Hennersperger; Matthias Eiber; Christine Kroll; Hubert Kübler; Tobias Maurer; Fausto Milletarì; Julia Rackerseder; Christian Schulte Zu Berge; Enno Storz; Benjamin Frisch; Nassir Navab
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-06-09       Impact factor: 2.924

7.  Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.

Authors:  Sabrina Dewes; Kilian Schiller; Katharina Sauter; Matthias Eiber; Tobias Maurer; Markus Schwaiger; Jürgen E Gschwend; Stephanie E Combs; Gregor Habl
Journal:  Radiat Oncol       Date:  2016-05-26       Impact factor: 3.481

8.  Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.

Authors:  Lorenzo Tosco; Annouschka Laenen; Thomas Gevaert; Isabelle Salmon; Christine Decaestecker; Elai Davicioni; Christine Buerki; Frank Claessens; Johan Swinnen; Karolien Goffin; Raymond Oyen; Wouter Everaerts; Lisa Moris; Gert De Meerleer; Karin Haustermans; Steven Joniau
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.